
Korsana Biosciences
Quarterly Financials
| Values in thousands | 2026-09-30 | 2025-12-31 |
|---|---|---|
Revenue | $0 | $1,025 |
Gross Profit | -33 | 1,025 |
EBITDA | -48,274 | -799 |
EBIT | -48,274 | -14,969 |
Net Income | -46,425 | -799 |
Net Change In Cash | 0 | 1,025 |
Free Cash Flow | -47,126 | -1,579 |
Cash | 456,221 | 3,240 |
Basic Shares | 135 | 5,061 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2022-12-31 |
|---|---|---|---|
Revenue | $2,074 | $2,000 | $297 |
Gross Profit | 2,074 | 2,000 | -5,282 |
EBITDA | -3,528 | -3,057 | -18,181 |
EBIT | -37,291 | -109 | -18,246 |
Net Income | -3,528 | -3,057 | -44,078 |
Net Change In Cash | 2,074 | 2,000 | 297 |
Free Cash Flow | -3,314 | -4,333 | -40,611 |
Cash | 3,240 | 3,232 | 13,382 |
Basic Shares | 5,041 | 5,041 | 2,173 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-09-30 | -$3.19 |
2026-06-30 | -$2.88 |
2026-03-31 | -$5.28 |
2025-12-31 | -$0.19 |